Deluxe Corporation

Fundamentals6.0
Price Action6.0
News Sentiment6.0
AI Rating
6.0

Key Drivers

  • Strong gross margin
  • High leverage
  • Robust free cash

AI
AI Summary

6.0

Deluxe has materially re‑pivoted from legacy print to higher‑margin payments and data with demonstrable FCF today, but elevated net leverage, tight liquidity, and the dividend vs. deleveraging tradeoff mean investors should only add on clear, consecutive quarters of organic payments/data revenue growth and consistent FCF-led net-debt reduction.

Transition
Leverage
Execution‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

6.0

Key Financial Insights:

  • Strong gross margin
  • High leverage
  • Robust free cash

DLX delivers strong operating profitability and $175.3m FCF in FY2025 but thin net margins and tight liquidity amid high leverage and large intangibles, raising material downside risk.

CashFlow
LeverageRisk

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • below SMA
  • support cluster
  • failed re-tests

Short-term bias for DLX is mildly negative: price dropped ~4.7% over the last month to $25.96 and sits below the last month SMA (~$27.24), with nearest support at $26.00–$26.50 and resistance at $28.10–$28.50—watch a decisive break below the $26 band as a bearish trigger.

mildyNegative
watchSupport
Support Level: $26.00–$26.50
Resistance Level: $28.10–$28.50

Modest ~4.7% decline over the last month without sharp capitulation

Sentiment & News

6.0

Key News Insights:

  • Analyst consensus
  • Zacks Strong Buy
  • Institutional trimming

Analysts and screeners are increasingly bullish on Deluxe (DLX)—with a MarketBeat consensus Buy and multiple Zacks Strong Buy inclusions—while valuation debate and peer comparisons persist and one institutional holder trimmed its position.

Buy
Mixed

Positive analyst and screening momentum could support near-term upside, but valuation scrutiny and the recent institutional reduction may limit sustained gains